EU
Commission president announces 160 million doses of Moderna vaccine contract
European Commission President Ursula von der Leyen announced today (24 November) that the Commission will approve its 6th contract for a COVID-19 vaccine with an order for up to 160 million doses of the Moderna vaccine, recently found to have 95% effective in recent trials.
The Commission has also made orders with CureVacc, Pfizer/BioNTech, AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica. Once the vaccine is indeed proven as safe and effective, every member state will receive it at the same time on a pro-rata basis on the same conditions.
Share this article:
-
General2 days agoUK governance: The case of Njord Partners
-
Space4 days agoThe European Union is accelerating and reinforcing IRIS²
-
Italy5 days agoBertoldi’s 'The New Evil Empire': Mapping the alliances threatening the West
-
Environment4 days agoScaling up green transition in Southern Africa under Global Gateway: Climate Fund Managers reaches first close of SA-H2 Fund at ZAR 3 billion

